Skip to content

Jazz Pharmaceuticals JAZZ Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Efficiency
Asset turnover0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Liquidity
Current ratio+0.2×1.9×+0.2×1.7×0.0×1.6×-1.8×3.4×-1.1×
Leverage
Debt-to-equity1.2×-0.1×1.3×-0.1×1.4×-0.1×1.5×+0.2×1.3×-0.2×
Per Share
Book value per share$68.57-3.2%$70.82+10.2%$64.26+6.1%$60.57-11.5%$68.44+10.4%
Valuation
Market capitalization$11.64B+12.7%$10.33B+29.2%$7.99B+22.2%$6.54B-13.2%$7.54B+1.3%
Price / sales2.6×+0.2×2.4×+0.5×1.9×+0.3×1.6×-0.3×1.9×0.0×
Price / book2.6×+0.2×2.4×+0.4×+0.3×1.8×0.0×1.8×0.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Jazz Pharmaceuticals's ratios come from?
Every ratio is computed from Jazz Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.